Andrew Warren - Profile and Investment Details

Investor Profile

Andrew Warren is a Venture Capital, Accelerator, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics, Constellation Pharmaceuticals, Jounce Therapeutics, Motus Therapeutics, PanOptica, Warp Drive Bio, Editas Medicine, Ember Therapeutics, MOMA Therapeutics, Relay Therapeutics, Decibel Therapeutics, CytomX Therapeutics, Topica Pharmaceuticals, Cibiem, Inc., Alcresta, Rhythm Metabolic, Agios Pharmaceuticals, Rheos Medicines, Lotus Tissue Repair, Bluebird Bio, Corvia Medical, Afferent Pharmaceuticals, Foundation Medicine, Fulcrum Therapeutics, Voyager Therapeutics, Seventh Sense Biosystems, Maze Therapeutics, Neon Therapeutics, TARIS Biomedical, NinePoint MedicalAsher Bio, MyoKardia, Thrive Earlier Detection, Celsius Therapeutics, Igenica, Cedilla Therapeutics, Casma Therapeutics, Edimer Pharmaceuticals, Pliant Therapeutics, Sesen Bio, Inc., Element Science, Insitro, Soffio Medical, Revolution Medicines, HI-Bio, Faze Medicines, Ambys Medicines, Global Blood Therapeutics, Kala Pharmaceuticals, Rhythm Pharmaceuticals, Nurix Therapeutics, Tango Therapeutics, SAGE Therapeutics, Allena Pharmaceuticals, . Over time, Andrew Warren has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Andrew Warren is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Healthcare Innovation, Life Science, Engineering, Portfolio Management, Medical Technologies, Skill Assessment, Strategic Planning, Venture Fundraising, Finance, Bioinformatics, Biotechnology, Drug Development, Genomics, Clinical Trials, Research, Consulting, Personalized Medicine, Technology Transfer, Health Diagnostics, Digital Health, Regulatory Compliance, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals, Biometrics may find it worthwhile to explore potential connections with Andrew Warren, as their portfolio suggests a familiarity and interest in this area.

Understanding Andrew Warren’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.